A HEAD-TO-HEAD PHASE 3 STUDY COMPARING BGB-3111 AND IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA
Buske, C., LeBlond, V., Novotny, W., Owen, R., Tedeschi, A., Atwal, S., Cohen, A., Huang, J., Tam, C.S.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2440_5
Date:
June, 2017
File:
PDF, 132 KB
english, 2017